Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its activity across two incretin pathways. It is used as a reference compound in metabolic and receptor signalling research in vitro.
- Dual agonist at the GLP-1 and GIP receptors
- Used in pancreatic beta cell, hepatocyte and adipocyte models
- Applied in receptor binding and second messenger assays
- Reference compound for integrated incretin signalling studies
- Purity confirmed by RP-HPLC, identity by mass spectrometry
Research profile: Tirzepatide: structure, mechanism and research use
Independent test: a sample of this product was analysed by Janoshik Analytical on 17 October 2025, purity 99.84% by RP-HPLC. The certificate is shown in the lab band on this page.






